InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Browse the detailed record of transactions filed by Koppikar Utpal, Chief Financial Officer. Director active across 2 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 13 filings have been published. Total volume traded: €524k. The latest transaction was filed on 8 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
€30,7465,853 shares@ €5.2530.038% mcap9.3% of flow
Common Stock
SEC:0001567619-22-012667:0·
€23,2644,616 shares@ €5.03990.029% mcap7.0% of flow
Common Stock
SEC:0001140361-22-019988:0·
061,235 shares0
Common Stock
SEC:0001140361-22-007767:0·
€31,5112,496 shares@ €12.62450.024% mcap16.4% of flow
Common Stock
SEC:0001567619-22-003052·
€31,5112,496 shares@ €12.62450.039% mcap9.5% of flow
Common Stock
SEC:0001567619-22-003052:0·
€55,0413,655 shares@ €15.05910.042% mcap28.7% of flow
Common Stock
SEC:0001567619-21-020778·
€55,0413,655 shares@ €15.05910.067% mcap16.6% of flow
Common Stock
SEC:0001567619-21-020778:0·
€38,3033,579 shares@ €10.70220.029% mcap19.9% of flow
Common Stock
SEC:0001567619-21-016148·
€38,3033,579 shares@ €10.70220.047% mcap11.5% of flow
Common Stock
SEC:0001567619-21-016148:0·
€67,2235,820 shares@ €11.55030.051% mcap35.0% of flow
Common Stock
SEC:0001567619-21-011898·
€67,2235,820 shares@ €11.55030.082% mcap20.2% of flow
Common Stock
SEC:0001567619-21-011898:0·
€43,0413,616 shares@ €11.9028100.0% of flow
Common Stock
SEC:0001209191-21-034424·
€43,0413,616 shares@ €11.90280.053% mcap13.0% of flow
Common Stock
SEC:0001209191-21-034424:0·
13 of 13 declarations
About Koppikar Utpal
Utpal Koppikar is the Chief Financial Officer at Atara Biotherapeutics, Inc. He is responsible for financial management and strategy for the company. With a strong background in finance, Utpal plays a key role in optimizing financial performance and implementing growth strategies. His expertise in financial analysis is essential for informed decision-making.
